Panacea Biotec Ltd (531349) Stock Price & News

Panacea Biotec is a global generic and specialty pharmaceutical and vaccine maker. It has principal offices in New Delhi, Mumbai, and Lalru. It has business interests in research, development, manufacturing and marketing of pharmaceutical formulations, vaccines, biosimilars, and natural products. Wikipedia

About Panacea Biotec Ltd

CEO-

Employees2,1 k

Founded1984

Headquarters-

Sector-

Websitepanaceabiotec.com

All values in INR	Sep. 2025	Des. 2025	Mrt. 2026	Jun. 2026
Revenue	1,41 mjd	1,65 mjd	1,67 mjd	2,00 mjd
Cost of goods sold	589,40 m	679,30 m	763,93 m	1,02 mjd
Cost of revenue	589,40 m	679,30 m	763,93 m	1,02 mjd
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	477,10 m	405,30 m	607,88 m	441,60 m
Operating expense	1,08 mjd	939,70 m	849,37 m	1,00 mjd
Total operating expenses	1,67 mjd	1,62 mjd	1,61 mjd	2,02 mjd
Operating income	-261,30 m	32,90 m	54,24 m	-22,30 m
Other non operating income	64,00 m	22,80 m	-149,85 m	42,40 m
EBT including unusual items	-191,70 m	64,90 m	-12,49 m	35,70 m
EBT excluding unusual items	-218,70 m	37,20 m	-47,72 m	8,30 m
Income tax expense	-51,60 m	26,00 m	-2,46 m	13,70 m
Effective tax rate	26,92%	40,06%	19,70%	38,38%
Other operating expenses	522,70 m	449,90 m	162,69 m	480,30 m
Net income	-139,20 m	39,80 m	5,13 m	23,00 m
Net profit margin	-9,86%	2,41%	0,31%	1,15%
Earnings per share	-	-	-	-
Interest and investment income	-	-	41,64 m	-
Interest expense	-21,40 m	-18,50 m	-5,60 m	-11,80 m
Net interest expenses	-21,40 m	-18,50 m	36,04 m	-11,80 m
Depreciation and amortization charges	83,40 m	84,50 m	78,80 m	79,00 m
EBITDA	-177,60 m	113,44 m	129,51 m	60,35 m
Gain or loss from assets sale	-	-	-	-

Ask anything